Current treatment standards and future strategies in mantle cell lymphoma.
Dreyling
M
M
Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany.
Weigert
O
O
Hiddemann
W
W
D000970:Antineoplastic Agents / Q000592:standards* / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy / Q000592:standards*; D020522:Lymphoma, Mantle-Cell / Q000628:therapy*; D011878:Radiotherapy / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D033581:Stem Cell Transplantation
D000970:Antineoplastic Agents